Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development
Cycle Pharmaceuticals shook hands with US-based firm, Aprecia Pharmaceuticals as they agreed to develop and commercialize treatments for rare diseases using the advanced technology of 3D printing, recently reported Cambridge…